Common use of Research Programme Clause in Contracts

Research Programme. EVOTEC and BOEHRINGER wish to enter into a joint research collaboration in order to identify small chemical entity therapeutics which act as GPCR modulators. Their first and initial priority is GPCR targets **** but the collaboration may include additional GPCR target opportunities for other diseases, including but not limited to ****, ****, ****, **** and **** areas. The Parties acknowledge that EVOTEC OAI AG has entered into an exclusive collaboration in the area of ****. The GPCR Targets in the respective indication area will be determined by the appropriate committee in accordance with the provisions of Section 3. The Research Programme is also intended to generate proprietary know how with respect to GPCRs to be incorporated into ****. Targets shall be selected within the following classes: **** **** **** The Research Plan will be set up in accordance with Section 3. * Portions of this document marked with **** have been omitted pursuant to a request for confidential treatment submitted with the SEC.

Research Programme. EVOTEC and BOEHRINGER wish to enter into a joint research collaboration in order to identify small chemical entity therapeutics which act as GPCR modulators. Their first and initial priority is GPCR targets **** for CNS diseases but the collaboration may include additional GPCR target opportunities for other diseases, including but not limited to ****, ****, ****, **** and **** areas. The Parties acknowledge that EVOTEC OAI AG has entered into an exclusive collaboration in the area of ****. The GPCR Targets in the respective indication area will be determined by the appropriate committee in accordance with the provisions of Section 3. The Research Programme is also intended to generate proprietary know how with respect to GPCRs to be incorporated into ****. Targets shall be selected within the following classes: **** **** **** The Research Plan will be set up in accordance with Section 3. * Portions of this document marked with **** have been omitted pursuant to a request for confidential treatment submitted with the SEC.